← Leaderboards
Patricia Sue Grigson
Pennsylvania State Univ Hershey Med Ctr
$14,004,500
Attributed
$23,400,190
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,400,190 · 8
By mechanism
UH3$8,480,887 · 1
R01$6,007,645 · 3
UG3$5,421,883 · 1
R37$2,943,096 · 1
R21$432,111 · 1
R29$114,568 · 1
Top collaborators
- Scott C Bunce6 shared
- Timothy R. Brick2 shared
- Jonathan Foulds2 shared
- Jennifer E. Nyland2 shared
- Hock Seng Tan2 shared
- Stephen Jeffrey Wilson2 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Pankaj Kumar Singh$18,899,559
- Kevin Finnbar Staveleyo'carroll$5,239,458
- Thomas Y Ma$11,200,784
- Lisa M Shantz$2,147,221
- Mingjiang Xu$9,383,816
Others in their field
Top investigators on “Cocaine”
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Fred M Gordin · Social And Scientific Systems, Inc.$44,160,542
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,690,128
- Joel Gelernter · Washington University$34,364,949
- Michael A Nader · Emory University$33,226,167
- Shenghan Lai · University Of Miami Coral Gables$31,568,530
Research focus
CocaineSucroseMorphineRattusPharmaceutical PreparationsCuesRewardsDoseRelapseHeroinSelf AdministrationTaste PerceptionAddictionDopamineBehaviorFundingIntakeDrug AddictionConditioned StimulusReportingBehavioralChronicDrug Of AbusePublishing
Grant awards (40)
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$4,444,024
UH3 · FY2025 · DA · contact PI
Cocaine Addition and the Need-State Hypothesis$762,063
R01 · FY2025 · DA · contact PI
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$4,036,863
UH3 · FY2024 · DA · contact PI
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$145,779
UG3 · FY2021 · DA · contact PI
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$2,557,628
UG3 · FY2020 · DA · contact PI
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$351,281
UG3 · FY2020 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$345,974
R37 · FY2020 · DA · contact PI
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$2,367,195
UG3 · FY2019 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$345,974
R37 · FY2019 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$345,974
R37 · FY2018 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$345,974
R37 · FY2017 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$345,974
R37 · FY2016 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$302,857
R37 · FY2015 · DA · contact PI
Random nicotine delivery: A novel intervention for smokers$190,820
R21 · FY2015 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$307,514
R37 · FY2014 · DA · contact PI
Random nicotine delivery: A novel intervention for smokers$241,291
R21 · FY2014 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$295,256
R37 · FY2013 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$307,599
R37 · FY2012 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$303,090
R01 · FY2011 · DA · contact PI
Drugs of Abuse, Reward Comparison, and the Thalamus$347,450
R01 · FY2010 · DA · contact PI
Drugs of Abuse, Reward Comparison, and the Thalamus$342,550
R01 · FY2009 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$272,260
R01 · FY2009 · DA · contact PI
Drugs of Abuse, Reward Comparison, and the Thalamus$275,216
R01 · FY2008 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$269,999
R01 · FY2008 · DA · contact PI
Drugs of Abuse, Reward Comparison, and the Thalamus$280,939
R01 · FY2007 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$275,576
R01 · FY2007 · DA · contact PI
Drugs of Abuse, Reward Comparison, and the Thalamus$289,436
R01 · FY2006 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$248,390
R01 · FY2006 · DA · contact PI
Drugs of Abuse and Learned Aversions: Solving a Paradox$254,642
R01 · FY2005 · DA
DRUGS OF ABUSE, REWARD COMPARISON, AND THE THALAMUS$269,325
R01 · FY2004 · DA
DRUGS OF ABUSE, REWARD COMPARISON, AND THE THALAMUS$298,420
R01 · FY2003 · DA
DRUGS OF ABUSE AND LEARNED AVERSIONS: SOLVING A PARADOX$178,128
R01 · FY2003 · DA
DRUGS OF ABUSE, REWARD COMPARISON, AND THE THALAMUS$269,325
R01 · FY2002 · DA
DRUGS OF ABUSE AND LEARNED AVERSIONS: SOLVING A PARADOX$172,941
R01 · FY2002 · DA
DRUGS OF ABUSE, REWARD COMPARISON, AND THE THALAMUS$28,330
R01 · FY2002 · DA
DRUGS OF ABUSE, REWARD COMPARISON, AND THE THALAMUS$269,325
R01 · FY2001 · DA
DRUGS OF ABUSE AND LEARNED AVERSIONS: SOLVING A PARADOX$167,904
R01 · FY2001 · DA
DRUGS OF ABUSE, REWARD COMPARISON, AND THE THALAMUS$269,325
R01 · FY2000 · DA
DRUGS OF ABUSE AND LEARNED AVERSIONS: SOLVING A PARADOX$163,011
R01 · FY2000 · DA
NEURAL MECHANISMS OF GUSTATORY CONTRAST$114,568
R29 · FY2000 · DC